More
Accelerated approval for Genglycos (pariglasgene brecaparvovec), a gene therapy for GSDIa.
GSDIa forces constant fear of low blood sugar and lifelong dietary control. A first approved therapy means the disease is no longer something medicine could only manage by hand.
